Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple-Dose Targeting Study of hu3S193 in Patients With Small Cell Lung Cancer

NCT00084799 is registered in ClinicalTrials.gov with Ludwig Institute for Cancer Research as lead sponsor.

NCT NCT00084799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00084799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple-Dose Targeting Study of hu3S193 in Patients With Small Cell Lung Cancer
Lead sponsor
Ludwig Institute for Cancer Research
Phase
Phase 1
Overall status
Completed
Start date
July 26, 2004
Completion date
December 20, 2006
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer